Two pharmaceutical companies, InvaGen Pharmaceuticals and Alphamed Realty, will construct two separate facilities---one for manufacturing and distribution, and another for bottling, packaging, and distribution--on 18-acres of surplus city-owned property they will purchase for $3.5 million in Central Islip, Long Island, New York. These facilities will be built across the street from another related company, Ascent Pharmaceuticals, which is already open and operational.

InvaGen manufactures a variety of pharmaceuticals for the medical industry, including cardiovascular, anti-inflammatory and anti-diabetic medicines. while AlphaMed manufactures and distributes bottles for the pharmaceutical industry, including InvaGen.

Both companies will receive substantial financial benefits from Islip’s Industrial Development Agency, enabling the construction of a 260,000-square-foot facility for InvaGen, and an 80,000-square-foot facility for AlphMed. InvaGen will invest as much $37 million in its project, which will result in the retention of 390 jobs and the creation of 100 more, while AlphaMed will spend nearly $10 million and retain 15 jobs and create an additional 20.

“The decision to expand operations in Islip Town was an easy one, with the programs the Town provided,” said Sudhakar Vidiyala, owner of InvaGen Pharmaceuticals, Inc., and AlphaMed Bottles. “We extend our gratitude to the Town of Islip Industrial Development Agency for the assistance provided.”

According to Islip economic development officials, the initiative to consolidate government space and streamline surplus municipal property was spearheaded by Islip Councilwoman Trish Bergin Weichbrodt, as a way to create additional revenue. The “surplus” property on Carleton Avenue will net taxpayers $3.5 million. The 18 acres had been part of the Central Islip Department of Public Works Highway Yard, and before that, was part of the Central Islip Psychiatric Center for more than 100 years.

“Selling surplus land that the Town isn’t using anymore is the prudent and fiscally responsible thing to do for our taxpayers,” said Councilwoman Bergin Weichbrodt. “In this case, we were able to attract emerging pharmaceutical companies to an area that wasn’t being utilized, companies that will generate never before realized tax dollars.”